Haemonetics Free Cash Flow Per Share 2010-2025 | HAE

Haemonetics free cash flow per share from 2010 to 2025. Free cash flow per share can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.173B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $228.441B 27.47
Boston Scientific (BSX) United States $154.602B 38.70
Stryker (SYK) United States $143.752B 30.06
EssilorLuxottica (ESLOY) France $130.179B 0.00
Medtronic (MDT) Ireland $103.476B 14.67
Haleon (HLN) United Kingdom $50.182B 28.56
Lonza Group Ag (LZAGY) Switzerland $49.251B 0.00
ResMed (RMD) United States $35.607B 26.74
GE HealthCare Technologies (GEHC) United States $31.667B 15.03
Agilent Technologies (A) United States $30.942B 20.44
Terumo (TRUMY) Japan $27.686B 35.96
Insulet (PODD) United States $22.616B 88.77
Koninklijke Philips (PHG) Netherlands $21.196B 15.24
Zimmer Biomet Holdings (ZBH) United States $18.329B 11.77
Baxter (BAX) United States $15.457B 11.54
Smith & Nephew SNATS (SNN) United Kingdom $12.539B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.090B 21.19
Lantheus Holdings (LNTH) United States $5.110B 12.89
Prestige Consumer Healthcare (PBH) United States $4.237B 18.93
Perrigo (PRGO) Ireland $3.651B 9.25
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.175B 23.41
Envista Holdings (NVST) United States $2.834B 23.55
GN Store Nord (GNNDY) Denmark $2.054B 17.01
QuidelOrtho (QDEL) United States $2.011B 13.83
LeMaitre Vascular (LMAT) United States $1.839B 41.11
AtriCure (ATRC) United States $1.619B 0.00
Neogen (NEOG) United States $1.315B 16.83
Acuren (TIC) United States $1.272B 0.00
AdaptHealth (AHCO) United States $1.185B 12.03
Green Thumb Industries (GTBIF) United States $1.145B 25.76
Kestra Medical Technologies (KMTS) United States $1.139B 0.00
BioLife Solutions (BLFS) United States $1.035B 0.00
Phibro Animal Health (PAHC) United States $0.942B 12.04
InMode (INMD) Israel $0.899B 9.06
Evolus (EOLS) United States $0.624B 0.00
CeriBell (CBLL) United States $0.599B 0.00
Curaleaf Holdings (CURLF) Canada $0.569B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.565B 0.00
Valneva SE (VALN) France $0.517B 0.00
Owens & Minor (OMI) United States $0.498B 4.13
Capricor Therapeutics (CAPR) United States $0.468B 0.00
Tilray Brands (TLRY) Canada $0.445B 0.00
Surmodics (SRDX) United States $0.410B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.339B 0.00
Canopy Growth (CGC) Canada $0.336B 0.00
Cresco Labs (CRLBF) United States $0.325B 0.00
VAREX IMAGING (VREX) United States $0.310B 11.39
Aurora Cannabis (ACB) Canada $0.309B 55.00
Sanara MedTech (SMTI) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.254B 21.40
Verano Holdings (VRNOF) United States $0.248B 0.00
Sanuwave Health (SNWV) United States $0.244B 0.00
Cerus (CERS) United States $0.239B 0.00
ZimVie (ZIMV) United States $0.231B 10.48
TriSalus Life Sciences (TLSI) United States $0.210B 0.00
Brainsway (BWAY) Israel $0.203B 53.65
Biote (BTMD) United States $0.201B 5.66
OraSure Technologies (OSUR) United States $0.189B 0.00
Quanterix (QTRX) United States $0.188B 0.00
Omeros (OMER) United States $0.185B 0.00
High Tide (HITI) Canada $0.185B 0.00
Organigram Global (OGI) Canada $0.183B 0.00
Utah Medical Products (UTMD) United States $0.175B 14.22
Exagen (XGN) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.137B 16.86
Jin Medical (ZJYL) China $0.123B 0.00
TerrAscend (TSNDF) Canada $0.119B 0.00
Agape ATP (ATPC) $0.103B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Fonar (FONR) United States $0.088B 11.30
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Veru (VERU) United States $0.073B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.071B 0.00
Jushi Holdings (JUSHF) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Apyx Medical (APYX) United States $0.058B 0.00
United Health Products (UEEC) United States $0.054B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
Modular Medical (MODD) United States $0.046B 0.00
United-Guardian (UG) United States $0.037B 12.92
Rockwell Medical (RMTI) United States $0.033B 0.00
Nephros (NEPH) United States $0.031B 41.71
Safety Shot (SHOT) United States $0.031B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00